Aandelen in “Farmaceutische producten: Andere”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Farmaceutische producten: Andere”

30/09 · Nieuw Belgisch biotechfonds al meer dan 125 miljoen euro groot · Tijd.be (€)

30/09 · Nieuw Belgisch biotechfonds al meer dan 125 miljoen euro groot · Tijd.be (€)

In barre financieringstijden is het succes van het nieuwe, internationaal gespijsde fonds van Bioqube Ventures een opsteker voor biotechbedrijven. Oud-Argenx-voorzitter Peter Verhaeghe deelt er zijn ervaring en netwerk....

29/09 · AB Science provides an update on its development plan and financial calendar following a sponsor Good Clinical Practice inspection · Persbericht

29/09 · ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH · Persbericht

26/09 · Did BellRing Brands, Inc. Insiders Breach their Fiduciary Duties to Shareholders? · Persbericht

24/09 · Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure · Persbericht

22/09 · Argenx-concurrent Amgen boekt succes bij Sjögren, maar analisten missen cruciale cijfers · Tijd.be (€)

Amgen heeft met een experimenteel middel tegen de auto-immuunziekte Sjögren een belangrijke studie doen slagen. Dat vergroot de concurrentiedruk op Argenx, al ontbreken nog de cijfers om te beoordelen hoe sterk het middel...

17/09 · Virbac : Half-Year report 2026 · Persbericht

17/09 · Virbac : Public release of the Half-Year Financial Report at 30 June 2026 · Persbericht

17/09 · VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4% · Persbericht

16/09 · Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond · Persbericht

16/09 · MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

15/09 · Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences · Persbericht

14/09 · Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts · Persbericht

14/09 · MySize Announces Acquisition-Led Strategy Focused on Defense Technology · Persbericht

14/09 · Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression · Persbericht

10/09 · Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference · Persbericht

10/09 · BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) · Persbericht

9/09 · Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation · Persbericht

9/09 · Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business · Persbericht

8/09 · Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets · Persbericht

Mijn selecties